Step 1 — Submit records. Upload pathology slides (PDF + scanned images), radiology (DICOM via secure portal or wetransfer), molecular diagnostics, prior treatment lines and ECOG score to jz_lcl@163.com. We sign a bilateral NDA within 1 day.
Step 2 — Multidisciplinary review. A tumour board of 3 senior hematologists + 1 cell-therapy specialist reviews the case. They issue a written opinion (English) within 5 business days, including CAR-T target recommendation, eligibility, expected response rate, conditioning regimen and risk stratification.
Step 3 — 30-minute video consultation. Patient + family attend a free video call with the attending physician to discuss the opinion, ask questions, and align on logistics.
Step 4 — Decision. Patient decides within 14 days whether to proceed. No payment is taken until the visa invitation letter is signed and the deposit is wired.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Step 1 — Free pre-evaluation. Email jz_lcl@163.com with your latest pathology report, imaging (DICOM), molecular diagnostics, prior treatment lines and ECOG score. Our medical board returns a written opinion within 3 business days, confirming whether CAR-T is clinically appropriate.
Step 2 — Formal acceptance letter. If accepted, we issue an official Medical Treatment Confirmation Letter on company letterhead (English + Chinese bilingual), signed by the attending physician, stating the diagnosis, proposed therapy, planned admission window and approximate treatment duration.
Step 3 — Visa invitation. SaiAo Biotech is registered with the Shenzhen Exit-Entry Administration and can issue a Invitation Letter for Foreign Patients (PU invitation) within 2 business days. Bring the letter, confirmation, passport and photos to the nearest Chinese consulate or visa centre to apply for an M-visa （180 days).
Typical timeline. 7–14 days from first email to visa in hand, depending on your country of citizenship and consular workload.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Yes — up to 3 family members. Up to 3 immediate family members (spouse, parents, adult children) can be included on the SaiAo Biotech PU invitation letter at no extra cost.
Companion visa. Family members apply for an S1 visa (90 dasy) or S2 visa (≤180days) at the same Chinese consulate using the same PU letter plus proof of kinship (marriage certificate, birth certificate, notarised in home country).
Accommodation. Family members may stay in the hospital companion room (RMB 280/night, includes breakfast) or in one of our partner hotels within 5 minutes' walk — discounted rates negotiated for SaiAo patients.
During ICU. When the patient is transferred to ICU, family members can wait in the family lounge 24/7; daily 30-minute video visits with the ICU team are scheduled.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Standard schedule (auto CAR-T). Plan for 4–6 weeks in Shenzhen: Week 1 in-country registration + apheresis; Week 2 manufacturing (off-site, patient can rest); Week 3 lymphodepletion + CAR-T infusion + 14-day inpatient monitoring; Week 4–6 post-infusion observation + early response assessment.
Standard schedule (allogeneic / off-the-shelf). Plan for 3–4 weeks: no apheresis, immediate lymphodepletion, 14-day inpatient monitoring and 1–2 weeks of outpatient observation.
Extended stay criteria. Severe CRS / ICANS, GvHD or delayed hematologic recovery may extend the stay by 2–4 additional weeks. We will not discharge a patient until ANC > 1.0 × 10⁹/L for 3 consecutive days and CRS / ICANS fully resolved.
Buffer. We recommend booking return flights with flexible rebooking for at least 14 days after the planned discharge date.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
Option 1 — Hospital companion room. Inside the ward area, includes single bed, ensuite bathroom, breakfast and weekly linen change. Ideal for the first 14 days of monitoring.
Option 2 — Partner service apartments. 5-minute walk from the hospital, RMB 380–580/night for a 1-bedroom unit with kitchenette. Discounted 30% for stays > 21 days. Laundry, Wi-Fi and twice-weekly cleaning included.
Option 3 — International hotel. 4-star options (Marriott, Hilton, Sheraton) within 10 km, RMB 700–1,200/night. Suitable for extended pre/post-treatment stays.
Long-stay packages. For total stays > 28 days we offer a flat-rate package at RMB 12,000 covering companion-room accommodation for one family member and patient transfers.
SaiAo Biotech operates a dedicated International Patient Service Center in Shenzhen. Our case managers respond within 24 hours in English, Arabic, Russian, Vietnamese, Indonesian and Mandarin.
This FAQ is for general informational purposes and does not constitute medical advice. Final treatment decisions must be made by qualified physicians based on full medical records.
